Elliott Cohen

Title: Innovations by Elliott Cohen: A Pioneer in Diuretic Research

Introduction

Elliott Cohen is a notable inventor based in Pearl River, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of diuretics. With a total of 2 patents, his work has had a meaningful impact on medical treatments related to hyperaldosteronism.

Latest Patents

Cohen's latest patents include a method for antagonizing aldosteronic action and inducing diuresis through novel 1-(phenyl or p-chlorophenyl)-2,4-disubstituted-3-methylimidazolidines. This innovative approach aims to provide effective treatment options for patients suffering from conditions related to aldosterone. Another significant patent involves tetrasubstituted imidazolidine diuretics, which are useful in treating hyperaldosteronism by the administration of 1-(phenyl or p-chlorophenyl)-2,4(imino, methylimino or oxo)-disubstituted-3-methylimidazolidines.

Career Highlights

Cohen has been associated with the American Cyanamid Company, where he has furthered his research and development efforts. His work has been instrumental in advancing the understanding and treatment of diuretic-related conditions.

Collaborations

Throughout his career, Cohen has collaborated with esteemed colleagues such as John W Hanifin, Jr and Robert Zalmon Gussin. These partnerships have contributed to the success of his innovative projects.

Conclusion

Elliott Cohen's contributions to diuretic research exemplify the importance of innovation in medicine. His patents and collaborations highlight his commitment to improving patient care through scientific advancements.